gMG Connect
  • Saved


Meaning: Treatment with rituximab can be considered early after onset of generalized myasthenia gravis to reduce the risk of disease worsening and/or need of additional therapies.

  • Saved

made a Post

Highlights from the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) to learn from one another through plenary sessions and workshops that focused on the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy. Click above for a summary of the last two days of the conference. We will follow this up with a post-conference wrap-up report soon.

  • Saved

made a Post

Highlights from the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) to learn from one another through plenary sessions and workshops that focused on the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy. Click above for a summary of the last two days of the conference. We will follow this up with a post-conference wrap-up report soon.

 

  • Saved

made a Post

Highlights from the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) to learn from one another through plenary sessions and workshops that focused on the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy. Click above for a summary of the last two days of the conference. We will follow this up with a post-conference wrap-up report soon.

 

  • Saved

made a Post

Highlights from the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) to learn from one another through plenary sessions and workshops that focused on the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy. Click above for a summary of the last two days of the conference. We will follow this up with a post-conference wrap-up report soon.